Company Filing History:
Years Active: 2019-2025
Title: **Inventor Kentaro Nakashima: Pioneering Innovations in Patch Technology**
Introduction
Kentaro Nakashima, an innovative inventor based in Tosu, Japan, has made significant contributions to the field of pharmaceutical patches through his inventive spirit. With a total of three patents to his name, Nakashima is recognized for his work in developing advanced adhesive technologies that enhance the efficacy of transdermal drug delivery systems.
Latest Patents
Among his latest inventions, Nakashima has developed a lidocaine-containing patch that offers a unique formulation. This patch comprises an adhesive layer on a backing layer, integrating lidocaine or a pharmaceutically acceptable salt, propylene glycol, a rubber adhesive base, and a terpene resin. The composition is meticulously designed with a lidocaine content of 2 mass % to 6 mass % in relation to the total mass of the adhesive layer. Additionally, the ratio of lidocaine to propylene glycol is set between 1:0.6 to 1:1.8, with terpene resin content ranging from 5 mass % to 18 mass %.
Another notable invention is a non-aqueous adhesive patch that includes a backing layer and an adhesive agent layer featuring a unique combination of nonylic acid vanillylamide, terpene-based resin, rosin-based resin, a styrene-isoprene-styrene block copolymer, and liquid paraffin. The specified mass ratios of these components ensure the adhesive properties are optimized, with particular attention to the balance between the terpene-based resin and rosin-based resin, as well as the styrene-isoprene-styrene block copolymer and liquid paraffin.
Career Highlights
Kentaro Nakashima is currently affiliated with Hisamitsu Pharmaceutical Company, Inc., where he continues to push the boundaries of pharmaceutical innovation. His dedication to research and development in this arena has earned him recognition within the industry, showcasing his commitment to improving patient care through advanced drug delivery systems.
Collaborations
Throughout his career, Nakashima has collaborated with talented colleagues, including Masahiro Sato and Takaaki Yoshinaga. These partnerships within Hisamitsu Pharmaceutical Company enrich the collaborative environment that fosters innovation, allowing for the successful advancement of promising projects.
Conclusion
Kentaro Nakashima represents the spirit of innovation within the pharmaceutical sector, leveraging his expertise to create effective patches that improve patient comfort and treatment outcomes. His contributions to patch technology illustrate the impact of diligent research and collaboration in developing groundbreaking solutions in healthcare.